SCHEMBL28613438

SCHEMBL28613438

COCc1csc2c(S(C)(=O)=O)ncnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28616833 0.85 GPR119 (0.32)
SCHEMBL30808298 0.85 GPR119 (0.32)
SCHEMBL15751094 0.75 GPR35 (0.31)
SCHEMBL30808058 0.74 YTHDC1 (0.34)
SCHEMBL21823128 0.74 ALDH1A1 (0.34)
SCHEMBL30808281 0.72 PIP4K2C (0.42)
SCHEMBL28606328 0.72 PIP4K2C (0.42)
SCHEMBL28613381 0.69 PDPK1 (0.49)
SCHEMBL12505973 0.68 GPR119 (0.51)
SCHEMBL28610278 0.65 AR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113039182-B Inhibitors of YAP/TAZ-TEAD interactions and their use in cancer treatment 伊文蒂瓦公司 2024-02-20 CN disclosed
CN-113039182-A Inhibitors of YAP/TAZ-TEAD interaction and their use in cancer treatment 伊文蒂瓦公司 2021-06-25 CN disclosed